Novo Nordisk’s next obesity battlefront: Winning beyond America
CNBC Top News ·
Wegovy semaglutide tablets. Michael Siluk | Universal Images Group | Getty Images Novo Nordisk has told CNBC how it is preparing to go "all in" on launching its Wegovy pill outside the U.S, as the …
Wegovy semaglutide tablets. Michael Siluk | Universal Images Group | Getty Images Novo Nordisk has told CNBC how it is preparing to go "all in" on launching its Wegovy pill outside the U.S, as the battle for dominance of the weight-loss market goes global. "When we launch, we'll go all in," Novo's Executive Vice President for International Operations, Emil Kongshøj Larsen, told CNBC in an interview on Tuesday. …
Original source: CNBC Top News